Key Takeaways
- Apple exceeded earnings expectations, projecting strong iPhone growth and a China rebound.
- Amazon's AWS revenue surged 20%, easing AI deal concerns and significantly boosting its stock.
- Meta's increased AI capital expenditures led to a notable 13% stock decline.
- Coinbase reported over $1 billion in revenue and doubled its share buyback program to $2 billion.
- Eli Lilly's stock jumped 4% driven by high demand for its obesity drugs, Zetbound and Mounjaro.
- The restaurant sector showed weakness, with Chipotle lowering forecasts due to reduced consumer spending.
- Analysts forecasted further declines for gold prices despite a 50% year-to-date gain.
Deep Dive
- Apple reported $1.85 EPS and $102.47 billion in revenue, beating expectations.
- Services revenue increased 15% year-over-year to $16.24 billion.
- Despite a 3.5% sales decrease in China, CEO Tim Cook expects a return to growth this quarter due to strong iPhone 17 family reception.
- Apple guided for 10-12% overall revenue growth and double-digit iPhone revenue growth for the December quarter.
- Amazon shares surged following a strong earnings report, with AWS revenue up 20%.
- This performance eased concerns about losing AI deals, as AWS reported strong demand for AI and core infrastructure.
- The company's backlog grew to $200 billion, with unannounced deals potentially increasing this further.
- Amazon's stock increased 13% post-earnings, breaking through prior highs.
- The NASDAQ dropped 1.5% as investors reacted to Meta's significant increase in AI capital expenditures.
- Meta's shares fell 13%, marking its worst day in three years, despite an announced U.S.-China trade truce.
- Analysts suggest a need for monetization of AI investments, contrasting with Apple's lower CapEx.
- The market's after-hours trading showed a positive response to other strong earnings reports.
- Coinbase traded higher after hours following a report of revenues exceeding $1 billion, a 37% increase from the previous quarter.
- The company doubled its share buyback program to $2 billion.
- A guest analyst noted Coinbase's revenue is tied to trading volumes and Bitcoin's current stagnation.
- The speaker expressed a preference for buying Bitcoin directly over Coinbase shares.
- A panelist suggested a potential bullish reversal for Roku, despite its recent performance.
- Concerns were raised by some panelists regarding Netflix's 10-for-one stock split, viewing it as a potentially desperate move.
- Roku stock was down approximately 6% after market hours due to streaming hours falling short of analyst expectations.
- Netflix's 10-for-one stock split is scheduled to take effect with shares trading on a new post-split basis on November 7th.
- Amazon projects full-year capital expenditures of $125 billion, with further increases expected in 2026, primarily for AWS AI demand.
- Apple's guidance indicates an average of 10% iPhone growth over upcoming quarters, a significant improvement from prior years.
- Gene Munster noted Apple's specific iPhone guidance, a level of detail not seen since 2019, as a positive sign for investors.
- Apple's CFO projects a $1.4 billion tariff impact for the December quarter, while maintaining 47-48% profit margins.
- Gold, despite a small gain, remains 8% below its record highs.
- Analyst Carter Worth predicts further declines, citing a 'head and shoulders top' chart pattern and projecting a move to $3,600.
- Other analysts agreed on the potential for a decline, possibly linked to an equity market sell-off.
- Gold is up over 50% year-to-date, its best performance in half a century.
- Eli Lilly's stock surged 4% following strong earnings driven by high demand for its drugs Zetbound and Mounjaro.
- Mounjaro and Zepbound combined for $10 billion in revenue out of Eli Lilly's $17 billion total revenue.
- Novo Nordisk's unsolicited bid for Metsera is seen as aggressive and potentially desperate by a healthcare strategist.
- The price of GLP-1 drugs has decreased significantly, from $1,100-$1,200 per month to $400-$500.